TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 1.994
AS - Asia 1.256
EU - Europa 829
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 50
OC - Oceania 2
Totale 4.488
Nazione #
US - Stati Uniti d'America 1.896
SG - Singapore 372
CN - Cina 310
IT - Italia 257
HK - Hong Kong 228
BR - Brasile 201
RU - Federazione Russa 155
VN - Vietnam 141
DE - Germania 97
FR - Francia 84
IE - Irlanda 79
BD - Bangladesh 67
FI - Finlandia 46
GB - Regno Unito 46
CA - Canada 42
IN - India 24
ZA - Sudafrica 20
IQ - Iraq 19
AR - Argentina 18
JP - Giappone 14
SE - Svezia 13
TR - Turchia 12
MX - Messico 11
NL - Olanda 11
EC - Ecuador 10
VE - Venezuela 10
IL - Israele 9
EG - Egitto 8
SA - Arabia Saudita 8
BE - Belgio 7
CR - Costa Rica 7
NP - Nepal 7
PK - Pakistan 7
PR - Porto Rico 7
CO - Colombia 6
ES - Italia 6
GT - Guatemala 6
ID - Indonesia 6
KE - Kenya 6
BO - Bolivia 5
HN - Honduras 5
JM - Giamaica 5
CH - Svizzera 4
CL - Cile 4
CW - ???statistics.table.value.countryCode.CW??? 4
MA - Marocco 4
SC - Seychelles 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
GP - Guadalupe 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
SV - El Salvador 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PL - Polonia 2
PS - Palestinian Territory 2
SR - Suriname 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SZ - Regno dello Swaziland 1
Totale 4.396
Città #
San Jose 309
Hong Kong 227
Council Bluffs 194
Ashburn 179
Singapore 160
Dallas 120
Boardman 105
Chandler 95
Dublin 77
Beijing 67
Los Angeles 63
Lauterbourg 62
Ho Chi Minh City 60
Shanghai 52
Munich 48
New York 44
Moscow 37
Redondo Beach 37
Turku 29
Hanoi 28
Milan 28
Buffalo 25
Santa Clara 22
San Francisco 18
Helsinki 17
São Paulo 17
Petrópolis 16
Brooklyn 15
Columbus 14
Florence 14
Frankfurt am Main 14
Pavia 14
Düsseldorf 13
Johannesburg 13
Montreal 13
Orem 13
Brasília 12
Chicago 12
Atlanta 11
Da Nang 11
Princeton 10
The Dalles 10
Tokyo 10
Naples 9
Phoenix 9
Seattle 9
Boston 8
Catania 8
Chennai 8
Houston 8
Nuremberg 8
Rome 8
Stockholm 8
Baghdad 7
Brussels 7
Lawrence 7
Rio de Janeiro 7
Bari 6
Campinas 6
Guangzhou 6
Medford 6
Mira 6
Nairobi 6
North Bergen 6
Padova 6
Quito 6
Turin 6
Washington 6
Wilmington 6
Ankara 5
Kathmandu 5
Manchester 5
Queens 5
San Juan 5
Denver 4
Dhaka 4
Genoa 4
Haiphong 4
Las Vegas 4
Moncalieri 4
Newark 4
Osasco 4
Palermo 4
Pescara 4
Philadelphia 4
Porto Alegre 4
San José 4
Toronto 4
Travaco Siccomario 4
Verona 4
Willemstad 4
Zhengzhou 4
Biên Hòa 3
Cagliari 3
Caracas 3
Des Moines 3
Giza 3
Guatemala City 3
Guayaquil 3
Ha Long 3
Totale 2.639
Nome #
Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling 144
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 109
Model-based analysis of patient-derived organoids for evaluating anticancer drugs 105
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 103
From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation 100
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 96
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 95
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 93
Prone positioning is safe and may reduce the rate of intubation in selected covid-19 patients receiving high-flow nasal oxygen therapy 92
VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference 90
SERPINB3 modulates TGF-beta expression in chronic liver disease 89
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 88
SerpinB3 administration protects liver against ischemia-reperfusion injury 86
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 84
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 82
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 80
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 80
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 78
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment 75
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 74
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 70
Engineered EVs for Oxidative Stress Protection 69
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer 68
Protocol for high-yield bacterial expression and purification of the voltage-dependent anion channel 1 for high-throughput biophysical assays 67
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 65
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 64
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 64
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats 63
Inibitore di SerpinB3 per il trattamento della progressione di malattie croniche fibrosanti e di tumori primitivi 62
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 62
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 61
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 61
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 60
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 59
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 58
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 57
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 57
Characterization of the new isoform of squamous cell carcinoma antigen-1 (SCCA-PD) detected in hepatocellular carcinoma 56
Erratum: SERPINB3 is associated with longer survival in transgenic mice (Scientific Reports (2013) 3 (3056) DOI: 10.1038/srep03056) 56
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 54
The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis 53
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 52
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 50
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice 50
Hepatic progenitor cells express SerpinB3 49
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 48
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 48
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells 47
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 46
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 46
SERPINB3 is associated with longer survival in transgenic mice 46
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 45
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 44
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 44
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 43
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 43
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 41
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 41
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 41
MicroRNAs and SerpinB3 in hepatocellular carcinoma 40
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 39
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 39
Serpinb3 is overexpressed in the liver in presence of iron overload 38
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 38
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 36
Nintedanib treatment for idiopathic pulmonary fibrosis patients who have been switched from pirfenidone therapy: A retrospective case series study 34
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats 34
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 34
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 32
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 32
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 31
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker 30
Liver pro-oncogenic potential of SERPINB3 29
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 27
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism 22
Totale 4.488
Categoria #
all - tutte 24.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 1 2 2 8 16
2022/2023272 16 20 3 27 16 27 0 12 87 1 10 53
2023/2024328 14 71 24 19 42 50 35 7 2 8 23 33
2024/2025922 13 67 9 7 26 15 97 30 203 51 119 285
2025/20262.134 175 169 208 199 258 53 413 93 128 190 104 144
2026/2027794 60 168 159 259 148 0 0 0 0 0 0 0
Totale 4.488